Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Gastroenterol Hepatol ; 33(9): 1222-1228, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34397640

ABSTRACT

BACKGROUND: While the relation of mean platelet volume (MPV) with inflammatory diseases is obvious, its role in nonalcoholic fatty liver disease (NAFLD) without cardiovascular comorbidities, obesity and diabetes mellitus is not clear. METHODS: A total of 249 patients (nonobese, nondiabetic and not having cardiac diseases) who underwent an abdominal ultrasonography assessment were enrolled. They were divided according to the absence (group 1) or presence (group 2) of hepatic steatosis. The patients with steatosis were further divided according to the severity of steatosis as group 2a (grade 1), 2b (grade 2) and 2c (grade 3). The demographic and laboratory features were compared between groups. RESULTS: Hepatic steatosis was absent in 120 patients and detected in 129 patients (grade 1, 2, 3 hepatic steatosis in 75, 49 and 5 patients, respectively). BMI, aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio and serum AST, ALT, triglyceride levels were significantly higher in group 2 than in group 1 (P < 0.001, P < 0.001, P < 0.001, P = 0.005, P < 0.001, respectively). BMI, serum AST and triglyceride levels were significant factors for NAFLD (P < 0.001, P = 0.018, P = 0.001). MPV was neither different between groups (P > 0.05) nor a predictor factor for NAFLD (P > 0.05). CONCLUSION: MPV is a useless parameter to detect NAFLD without cardiovascular comorbidities, obesity and diabetes mellitus.


Subject(s)
Diabetes Mellitus , Non-alcoholic Fatty Liver Disease , Alanine Transaminase , Diabetes Mellitus/diagnosis , Diabetes Mellitus/epidemiology , Humans , Mean Platelet Volume , Non-alcoholic Fatty Liver Disease/diagnostic imaging , Non-alcoholic Fatty Liver Disease/epidemiology , Obesity/diagnosis , Obesity/epidemiology
2.
Am J Ind Med ; 56(6): 720-3, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23533056

ABSTRACT

UNLABELLED: A 26-year-old man with no significant past medical history presented to emergency department 1 hr after ingesting approximately 200 ml of HEDP 2010 organophosphoric acid corrosion inhibitor. He had normal vital signs, physical examination and biochemical parameters. After 24 hr, he developed nausea with a decreased urine output. While his blood urea nitrogen, creatinine and uric acid levels increased to 36 mg/dl, 3.87 mg/dl, and 8.4 mg/dl, respectively; his serum calcium and phosphorus levels decreased to 7.4 mg/dl and 1.4 mg/dl, respectively. He had proteinuria, glucosuria, leukocyturia and high phosphorus excretion in the urine. On ultrasonographic examination, the kidneys were slightly enlarged and edematous. On the third day of hospitalization, creatinine level increased to 8.81 mg/dl and metabolic acidosis developed. He underwent to hemodialysis therapy and renal functions improved uneventfully. CONCLUSION: This case represents an example of acute renal failure developed and recovering uneventfully after unintentionally ingestion of a bisphosphonate used in industry.


Subject(s)
Acute Kidney Injury/chemically induced , Acute Kidney Injury/therapy , Etidronic Acid/poisoning , Renal Dialysis/methods , Acute Kidney Injury/physiopathology , Adult , Blood Urea Nitrogen , Emergency Service, Hospital , Follow-Up Studies , Glomerular Filtration Rate , Humans , Kidney Function Tests , Male , Risk Assessment , Treatment Outcome , Turkey
SELECTION OF CITATIONS
SEARCH DETAIL